Metraipolis › archive › dc_9e6d60e47bd2
Durable Response to Glofitamab in HIV-Positive Refractory Burkitt Lymphoma: Case Report and Discussion — Europe PMC PMID:41694088
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41694088
- DOI
- 10.1002/jha2.70243
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T21:44:53.962Z
- SHA-256 of the archived text
ff5080c7df9b91c0bb7a274777df53791998fc0e65599a61a327db60d77316bc- Stable URL of this page
https://metraipolis.com/documento/dc_9e6d60e47bd2
How to cite
Durable Response to Glofitamab in HIV-Positive Refractory Burkitt Lymphoma: Case Report and Discussion — Europe PMC PMID:41694088 — Europe PMC (en), https://europepmc.org/article/MED/41694088 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9e6d60e47bd2 (Metraipolis archive dc_9e6d60e47bd2, sha256 ff5080c7df9b91c0bb7a274777df53791998fc0e65599a61a327db60d77316bc)
BibTeX
@misc{dc9e6d60e47bd2,
title = {Durable Response to Glofitamab in HIV-Positive Refractory Burkitt Lymphoma: Case Report and Discussion — Europe PMC PMID:41694088},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41694088},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9e6d60e47bd2; sha256 ff5080c7df9b91c0bb7a274777df53791998fc0e65599a61a327db60d77316bc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41694088. Agents can read the archived copy with the MCP tool read_document.